3 fantastic ASX shares that could be buys

These ASX shares could be in the buy zone this month…

| More on:
Investor riding a rocket blasting off over a share price chart

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you interested in adding some more ASX shares to your portfolio?

Three ASX shares that could be worth considering this month are listed below. Here's what you need to know about them:

Altium Limited (ASX: ALU)

The first ASX share to look at is Altium. It is an award-winning printed circuit board (PCB) design software provider. It could be worth considering due to its leading position in a market exposed to the Internet of Things and artificial intelligence booms. The proliferation of electronic devices is expected to lead to increasing demand for its software over the next decade.

This morning Citi upgraded its shares to a buy rating with a $35.40 price target. This compares to the latest Altium share price of $29.95

Appen Ltd (ASX: APX)

Another ASX share to consider is Appen. It has a million-plus team of crowd sourced experts preparing the data that goes into artificial intelligence and machine learning models. It does this for some of the biggest tech companies in the world such as Google and Facebook. While demand has been subdued recently and led to Appen falling short of expectations in the first half of FY 2021, it has been tipped to bounce back strongly. Especially given how the artificial intelligence and machine learning markets are forecast to grow materially in the future.

Citi remains positive on the company. It has a buy rating and $18.80 price target on its shares. This compares very favourably to the current Appen share price of $10.53.

Cochlear Limited (ASX: COH)

A final ASX share to look at is Cochlear. It is one of the world's leading hearing solutions companies and has a long track record of delivering earnings growth. While the pandemic was weighing on its performance, it has bounced back strongly recently. Looking longer term, the company appears well-placed for growth over the next decade. This is thanks to the ageing populations tailwind and its industry leading products.

Macquarie is very positive on the company's long term outlook. It has an outperform rating and $256.00 price target on its shares. The Cochlear share price is currently fetching $231.30.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Altium, Appen Ltd, and Cochlear Ltd. The Motley Fool Australia owns shares of and has recommended Altium and Appen Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »

A man sees some good news on his phone and gives a little cheer.
Growth Shares

5 incredible ASX growth stocks to buy for 2026

These growth stocks could be well-positioned for the long-term.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Growth Shares

These 2 ASX growth shares are ideal for Australians!

These businesses could be much bigger in a decade!

Read more »

A couple cheers as they sit on their lounge looking at their laptop and reading about the rising Redbubble share price
Growth Shares

2 super ASX growth stocks to buy in bunches in 2026

If you’re looking for growth in 2026, these two ASX stocks are still very much in expansion mode.

Read more »